In this study, higher adiponectin was associated with an increased risk of adverse renal outcomes in pre-dialysis CKD patients after adjusting for accepted risk factors including old age, diabetes, hypertension, smoking, and a sedentary lifestyle. This evidence concerns the gene ADIPOQ and diabetes mellitus.